Autoantibodies in cancer patients given Corynebacterium parvum/levamisole immunotherapy
Gatenby, P.A.; Basten, A.; Tattersall, M.H.; Fox, R.M.
Lancet 1(8177): 1082
1980
ISSN/ISBN: 0140-6736 PMID: 6103412 DOI: 10.1016/s0140-6736(80)91520-2Document Number: 450575
Document emailed within 0-6 h
Related Documents
Minton, J.P.; Rossio, J.L.; Dixon, B.; Dodd, M.C. 1976: The effect of Corynebacterium parvum on the humoral and cellular immune systems in patients with breast cancer Clinical and Experimental Immunology 24(3): 441-447Bast, R.C.; Knapp, R.C.; Mitchell, A.K.; Thurston, J.G.; Tucker, R.W.; Schlossman, S.F. 1979: Immunotherapy of a murine ovarian carcinoma with Corynebacterium parvum and specific heteroantiserum. I. Activation of peritoneal cells to mediate antibody-dependent cytotoxicity Journal of Immunology 123(5): 1945-1951
Chen, M.F.; Suzuki, H.; Yano, S. 1992: Induction of murine lymphokine-activated killer-like cells by Corynebacterium parvum (C. parvum) in vitro: lysis of tumor cells and macrophages by C. parvum-induced killer cells Anticancer Research 12(2): 451-456
Bjornsson, S.; Takita, H.; Kuberka, N.; Preisler, H.; Catane, H.; Higby, D.; Henderson, E. 1978: Combination chemotherapy plus methanol extracted residue of bacillus Calmette-Guérin or Corynebacterium parvum in stage IIi lung cancer Cancer Treatment Reports 62(4): 505-510
Marel, M.; Pospísil, M.; Fiserová, A.; Melínová, L.; Skácel, Z.; Bednár, M. 1990: Monitoring natural killer cell activity in the blood of patients with malignant pleural effusion after intrapleural administration of Corynebacterium parvum Casopis Lekaru Ceskych 129(16): 498-500
Padmanabhan, T.K.; Balaram, P.; Vasudevan, D.M. 1987: Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer. I. a three-year clinical follow up Neoplasma 34(5): 627-632
Medenica, R.; Girard, J.P.; Maurice, P. 1977: Clinical trial with Corynebacterium parvum Developments in Biological Standardization 38: 483-485
Zola, H. 1975: Mitogenicity of Corynebacterium parvum for mouse lymphocytes Clinical and Experimental Immunology 22(3): 514-521
Thatcher, N.; Swindell, R.; Crowther, D. 1979: Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly sequential study of melanoma patients. I. Changes in non-specific (NK, K and T cell) lymphocytotoxicity, peripheral blood counts and delayed hypersensitivity reactions Clinical and Experimental Immunology 36(2): 227-236
Douple, E.B. 1977: Treatment of an intracerebral rat brain tumor with Corynebacterium parvum and radiation National Cancer Institute Monograph 46: 179-184
Karakousis, C.P.; Didolkar, M.S.; Han, T. 1981: Chemoimmunotherapy (DTIC and Corynebacterium parvum) for disseminated malignant melanoma Cancer Treatment Reports 65(9-10): 925-926
Brisset, J.M.; Veillon, B.; Carmona, C. 1977: The local effect of intravesical Corynebacterium parvum in the dog. a preliminary study Developments in Biological Standardization 38: 379-380
Warr, G.W.; Sljivić, V.S. 1974: Enhancement and depression of the antibody response in mice caused by Corynebacterium parvum Clinical and Experimental Immunology 17(3): 519-532
Karakousis, C.P.; Didolkar, M.S.; Lopez, R.; Baffi, R.; Moore, R.; Holyoke, E.D. 1979: Chemoimmunotherapy (DTIC and Corynebacterium parvum) as adjuvant treatment in malignant melanoma Cancer Treatment Reports 63(11-12): 1739-1743
Kirchner, H.; Chmielarczyk, W.; Storch, E.; Schindler, L. 1984: Antiviral effects of Corynebacterium parvum and its effect on the interferon system in mice Behring Institute Mitteilungen 74: 183-188
Watson, S.R.; Sljivić, V.S. 1976: The role of macrophages in the adjuvant effect on antibody production of Corynebacterium parvum Clinical and Experimental Immunology 23(1): 149-153
Marx, A.; Sălăgeanu, A.; Olinescu, A.; Gancevici, G. 1987: Comparative immunological studies on Corynebacterium parvum polysaccharide and Fusobacterium varium lipopolysaccharide Archives Roumaines de Pathologie Experimentales et de Microbiologie 46(1): 57-65
Fisher, B.; Gebhardt, M.C.; Saffer, E.A.; Fisher, E.R. 1979: Effect of Corynebacterium parvum in prevention and reversal of atrophy of the liver following portacaval shunt Surgery Gynecology and Obstetrics 149(2): 168-172
Foresti, V.; Scolari, N.; Villa, A.; Parisio, E. 1989: Anatomical study of the fibrosing action of Corynebacterium parvum in malignant pleural effusion Minerva Medica 80(10): 1069-1072
Kiya, K.; Toge, T.; Harada, K.; Uozumi, T.; Hattori, T. 1981: Effect of intracerebral administration of Corynebacterium parvum on the growth of brain tumors in mice Gan 72(3): 446-450